PMA device
Blazer II Cardiac Ablation System and Cable
Boston Scientific Corp · Cardiac Ablation Percutaneous Catheter (LPB, Class III) · First FDA decision Dec 31, 2003, newest Aug 14, 2025Atrial fibrillation
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
7
PMA pathway
Device trials
3
Naming "Blazer II"
MAUDE reports
405
Brand "Blazer II", since 2015
PubMed studies
0
Mentioning "Blazer II"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Blazer II Cardiac Ablation System and Cable
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 7 decisions filed under this name.
- Blazer II Cardiac Ablation System and CablePMA supplement
P920047-S137 · Decided Aug 14, 2025 · 36 days after receipt · Normal 180 Day Track No User Fee
Device type: Cardiac ablation percutaneous catheter (LPB) · Cardiology
- Blazer II Cardiac Ablation Catheter and CablePMA supplement
P920047-S122 · Decided May 19, 2020 · 68 days after receipt · Normal 180 Day Track No User Fee
Device type: Cardiac ablation percutaneous catheter (LPB) · Cardiology
- BLAZER II CARDIAC ABLATION CATHETERPMA supplement
P920047-S073 · Decided Dec 8, 2014 · 178 days after receipt · Normal 180 Day Track No User Fee
Device type: Cardiac ablation percutaneous catheter (LPB) · Cardiology
3 more FDA decisions with a free account
Older decisions: P920047-S021
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Cardiac Catheterization Performed In Other Than A Hospital SettingNational analysisReview closedCAG-00166NUpdated Sep 16, 2026
- Cardiac Catheterization Performed in Other than a Hospital Setting - RETIREDNational determinationOn the books20.25Updated Dec 3, 2024
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33959CGS Administrators, LLCUpdated Oct 30, 2026
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33557Wellpoint FederalUpdated Jul 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Blazer II", any status and sponsor, newest update first.
- Radiofrequency Ablation of Paroxysmal Supraventricular Tachycardia Using a Novel Catheter Equipped With Mini ElectrodesPivotal-lookingCompleted
Yong Seog OhAcademic, hospital or other
NCT04215640 · 136 participants · Start Jan 13, 2020 · Primary completion Nov 1, 2021
Device: Microfidelity (MIFI) catheter; Conventional ablation catheter · For: Paroxysmal Supraventricular Tachycardia
Sites: Seoul, South Korea
- Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation TrialPivotal-lookingCompleted
Mayo ClinicAcademic, hospital or other
NCT00911508 · 2,204 participants · Start Nov 13, 2009 · Primary completion Dec 31, 2017
Device: Left atrial ablation · For: Atrial Fibrillation; Arrhythmia
Sites: Little Rock, Arkansas; Los Angeles, California; Sacramento, California · 118 sites in all
Mayo ClinicAcademic, hospital or other
NCT00578617 · 60 participants · Start Sep 2006 · Primary completion Feb 2009
Device: Ablation Therapy · For: Atrial Fibrillation; Arrhythmia
Sites: Birminham, Alabama; Los Angeles, California; Maywood, Illinois · 10 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Blazer II", and for the whole product code for context.
This brand
405 reports: 90 malfunction, 308 injury, 6 death
Whole product code LPB
14,593 reports: 5,424 malfunction, 8,535 injury, 628 death
Newest reports for this brand
- Blazer II HTD Temperature Ablation CatheterMalfunction
2124215-2026-55134 · Received Oct 16, 2026 · Event dated Sep 28, 2026
Device type: Cardiac Ablation Percutaneous Catheter (LPB)
Device problem as coded: Insufficient Heating
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Blazer II XPInjury
2124215-2026-55140 · Received Oct 16, 2026 · Event dated Mar 20, 2024
Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter (OAD)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Low Blood Pressure/ Hypotension; Cardiogenic Shock
- Blazer II XP Temperature Ablation CatheterMalfunction
2124215-2026-52972 · Received Oct 6, 2026 · Event dated Sep 25, 2026
Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter (OAD)
Device problem as coded: Temperature Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0202-2019 · Started Jun 20, 2018 · Posted by FDA Aug 28, 2018
Reason given: Reports of unintended continuation of radiofrequency (RF) energy delivery from the Cardiac ablation system after the foot switch has been released.
Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter (OAD)
Z-0973-2011 · Started Jul 14, 2009 · Posted by FDA Jan 27, 2011
Reason given: Product malfunction causes inadvertent delivery of energy.
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Cardiac Ablation Percutaneous Catheter (LPB)
Z-1617-2008 · Started Feb 14, 2008 · Posted by FDA Aug 30, 2008
Reason given: Package sterile barrier may be breached, compromising sterility.
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Catheter, Electrode Recording, Or Probe, Electrode Recording (DRF)
Published research
The most relevant PubMed records for "Blazer II"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LPB.
- Therapy Ablation Catheter (4mm and 8mm)Irvine Biomedical, Inc. · PMA 2022
- Navistar ThermocoolBiosense Webster, Inc. · PMA 2014
- EZ Steer ThermoCool CatheterBiosense Webster, Inc. · PMA 2021
- Chilli II Cooled Ablation Catheter and CableBoston Scientific Corp · PMA 2020
- Livewire Tc Ablation Catheter, Safire Ablation CatheterSt Jude Medical · PMA 2016
- Chilli Cooled Ablation SystemBoston Scientific Corp · PMA 2011
- Freezor Cardiac Cryoablation CatheterMedtronic Cryocath, LP · PMA 2022
- Biosense Webster CablesBiosense Webster, Inc. · PMA 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.